VersaBank (VBNK) Q4 Earnings Match Estimates

VersaBank reported adjusted Q results with EPS of $0.24, matching the Zacks consensus but below last year’s $0.28, while revenue rose to $25.29 million—4.2% above consensus and up from $19.98 million a year ago. The firm has only outperformed EPS estimates once in the past four quarters and its shares have lagged this year (-8.9% YTD vs S&P +16.3%); Zacks assigns a Hold (Rank #3). Consensus for the next quarter is $0.29 EPS on $25.67 million revenue and $1.50 EPS on $116.76 million for the fiscal year; near-term stock direction will likely depend on management commentary and whether analyst estimates are revised.

Analysis

VersaBank reported adjusted quarterly EPS of $0.24, in line with the Zacks consensus and down from $0.28 a year earlier, while revenue rose to $25.29 million for the quarter ended October 2025, beating consensus by 4.22% and improving from $19.98 million year‑over‑year. Results exclude non‑recurring items; the company has outperformed EPS estimates only once in the last four quarters despite delivering a +10% surprise the prior quarter (actual $0.22 vs. $0.20 expected).

Shares have lagged year‑to‑date, down roughly 8.9% versus a 16.3% gain for the S&P 500, and Zacks currently assigns a Rank #3 (Hold) to VBNK after a mixed trend in estimate revisions ahead of the print. Consensus estimates call for $0.29 EPS on $25.67 million revenue next quarter and $1.50 EPS on $116.76 million for the fiscal year; the Banks - Foreign industry sits in the top 26% of Zacks industries, which could moderate company‑specific headwinds.

Near‑term directional risk is concentrated in management’s earnings‑call commentary and whether analysts revise estimates upward; the company’s inconsistent record of beating EPS raises execution risk. Positive analyst revisions would likely catalyze outperformance given the revenue beat this quarter, while continued mixed revisions or weak guidance could extend underperformance relative to peers and the broader market.

Key Decisions for Investors

• Await the earnings‑call commentary and monitor analyst estimate revisions before adding to positions, as management guidance will likely determine near‑term direction
• If already long, consider holding modest exposure and set a clear re‑assessment trigger (upward revisions to next‑quarter EPS/revenue or constructive guidance), otherwise trim or hedge if estimates drift lower
• Use industry context—Banks - Foreign ranks in the top 26%—to weigh tactical additions only if company‑specific execution visibly improves and consensus estimates are revised higher